SEPN
Septerna, Inc.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Mar 1 ▲ Septerna announced positive Phase 1 results for SEP-631, an oral MRG…
- Jun 1 ▼ 1 insider sell $171.7K at $28.93
- Jun 12 ▼ 1 insider sell $219.2K at $35.08
- Jun 22 to Jul 1 ▼ 3 days of insider sells: $723.7K by 2 insiders, avg $35.29
- Jul 15 ▼ 1 insider sell $136.0K at $33.99
- Aug 3 ▼ 1 insider sell $114.9K at $34.47
- Aug 11 to Aug 12 ▼ 2 days of insider sells: $40.2M by 3 insiders, avg $43.79
- Sep 1 ▼ 1 insider sell $126.1K at $37.83
- Sep 10 Activist stake: Septerna, Inc. Announces Inducement Grant Under Nasdaq Lis…
- Oct 15 ▼ 1 insider sell $149.6K at $37.41
- Nov 4 FDA: Septerna Announces Selection of SEP-204 as Development Can…
- Nov 11 ▼ 1 insider sell $3.9M at $48.09
Signal stack
Where each data set points today.
- InsidersBEARISH
6 insiders sold $45.8M.
- InstitutionsBULLISH
Q2 2026: 17 added (1 new), 4 trimmed or exited. Largest new: Loomis Sayles & L P $20.9M.
- AnalystsBULLISH
15 of 16 rate it Buy or better. Every target is above the price.
- EstimatesRISING
Current-quarter EPS estimate −$0.552 → −$0.397 over 90 days. 2 up, 1 down in 30 days.
- Short sellersSTEADY
Short interest −4.8% to 3.35M shares. 11.9 days to cover, ≈7.2% of shares.
- TrendUPTREND
3% above its 50-day average. New closing high $52.34 on Nov 10.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| LOOMIS SAYLES & CO L P | NEW | $20.9M |
| BALYASNY ASSET MANAGEMENT L.P. | ADD | $11.7M |
| JACOBS LEVY EQUITY MANAGEMENT, INC | DOUBLED | $2.3M |
| MILLENNIUM MANAGEMENT LLC | TRIM | $1.7M |
| BARCLAYS PLC | DOUBLED | $1.7M |
| Nuveen, LLC | ADD | $1.6M |
| Russell Investments Group, Ltd. | DOUBLED | $1.3M |
| BANK OF AMERICA CORP /DE/ | ADD | $1.2M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
16 analystsPrice is below the lowest target. Median implies +44%.Targets as of Nov 16, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 10, 2026 | Stifel MAINTAIN | Buy |
| Nov 6, 2026 | Guggenheim MAINTAIN | Buy |
| Nov 4, 2026 | Wells Fargo MAINTAIN | Overweight |
| Aug 19, 2026 | JP Morgan MAINTAIN | Overweight |
| Aug 13, 2026 | Jones Trading MAINTAIN | Buy |
| Aug 12, 2026 | Wells Fargo MAINTAIN | Overweight |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Ezekowitz Alan Director Nov 11, 2026 | SELL | $319.2K |
Ezekowitz Alan Director Nov 11, 2026 | SELL | $620.6K |
Ezekowitz Alan Director Nov 11, 2026 | SELL | $1.1M |
Ezekowitz Alan Director Nov 11, 2026 | SELL | $1.5M |
Ezekowitz Alan Director Nov 11, 2026 | SELL | $207.3K |
Ezekowitz Alan Director Nov 11, 2026 | SELL | $102.5K |
Ezekowitz Alan Director Nov 11, 2026 | SELL | $54.8K |
Bhatt Elizabeth President and COO Oct 15, 2026 | EXERCISE | $27.2K |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.29 | -$0.69–-$0.24 | +4.0% | $21.8M |
| Next Q | -$0.39 | -$0.41–-$0.06 | -4.1% | $15.7M |
| Current FY | -$1.10 | -$1.35–-$0.74 | +7.4% | $92.7M |
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
19 filings · 4 press releases · 0 bullish · 6 bearish · 13 neutral- NEUTRAL 144Nov 12, 2026
Samsara BioCapital, L.P., a significant shareholder in Septerna, filed a Form 144 notice of intent…
Monitor for actual sale execution on Form 4 filings. The proposed sale by a pre-IPO investor may signal a desire to take profits post-IPO, but the filing alone does not confirm the sale will occur.
- NEUTRAL 144Nov 12, 2026
Director Jeffrey Finer filed a Form 144 notice of intent to sell 66,000 shares of Septerna common…
Monitor for actual sale execution on Form 4 filings. This is a routine director-level sale plan; no immediate read-through for the stock.
- NEUTRAL 144Nov 12, 2026
Director Alan Ezekowitz filed a Form 144 to sell 100,000 shares of Septerna, Inc. with an…
Monitor for additional insider selling patterns; a single director sale of this size is not unusual but could signal reduced conviction. The filing does not indicate a lock-up expiry or earnings…
- BEARISH PRESS-RELEASENov 9, 2026
Septerna reported Q3 2026 revenue of $18.9M (below consensus $20.8M) and a GAAP EPS loss of $0.57…
Monitor upcoming Phase 1 data for SEP-479 and SEP-204 in Q1 2027 as key catalysts. The revenue miss and wider loss may pressure the stock near-term, but the strong cash runway and pipeline…
All SEPN filing & press-release reports (23)
- 144 reportNov 12, 2026
- 144 reportNov 12, 2026
- 144 reportNov 12, 2026
- PRESS-RELEASE reportNov 9, 2026
- 8-K reportNov 4, 2026
- PRESS-RELEASE reportNov 4, 2026
- PRESS-RELEASE reportSep 10, 2026
- 3 reportSep 3, 2026
- 8-K reportAug 25, 2026
- CLUSTER reportAug 14, 2026
- CLUSTER reportAug 14, 2026
- 144 reportAug 12, 2026
- 144 reportAug 12, 2026
- 8-K reportAug 10, 2026
- PRESS-RELEASE reportAug 10, 2026
- CLUSTER reportJul 2, 2026
- CLUSTER reportJun 30, 2026
- 144 reportJun 26, 2026
- 144 reportJun 22, 2026
- 8-K reportApr 13, 2026
- PRESS-RELEASE reportApr 13, 2026
- PRESS-RELEASE reportMar 1, 2026
- INST-CLUSTER reportFeb 28, 2026